| Name | Title | Contact Details |
|---|
Grace Management, Inc. is a nationally recognized leader in delivering senior living management service. Grace Management was established in 1984 and has built a reputation not only as a business leader in the senior living industry, but also as having developed a family-driven approach. Grace Management communities include independent living, cottage and estate homes, assisted living, and memory care that offer a diverse array of services and amenities catered to the individual.
Marks Gray P.A is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prospect Medical Holdings, Inc. is a leading provider of healthcare services comprised of 22 hospitals and over 140 primary and specialty care clinics located throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. Established in 1996, Prospect Medical Holdings, Inc. has grown into a significant provider of coordinated regional healthcare services throughout Southern California, South Central Texas, Rhode Island, New Jersey, Connecticut, and Pennsylvania. We were among the first healthcare providers in the country to adopt an operating model, termed Coordinated-Regional-Care, that prefigures the objectives of the Affordable Care Act – to improve quality, reduce cost and enhance overall patient care. Our comprehensive network aims to provide coordinated, personalized care. We specialize in building comprehensive networks of quality healthcare services designed to meet the needs of our patients and members. Our goal is always to ensure high-quality outcomes. Above all, we are committed to quality in all aspects of healthcare delivery, including: 1. Striving for the best possible patient outcomes 2. Maintaining the highest standards of patient safety 3. Acting with integrity at all times 4. Promoting open communication 5. Collaborating to better serve the healthcare needs of our communities
Parish Anesthesia Associates is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.